Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions
NCT01331434
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
47
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
exemestane
Sponsor
Roxane Laboratories